{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:04:47Z","timestamp":1779242687460,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.ajo.2005.01.021","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:21:11Z","timestamp":1113834071000},"page":"867-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Successful Treatment of Gatifloxacin-resistant Staphylococcus aureus Keratitis With Zymar\u00ae (Gatifloxacin 0.3%) in a NZW Rabbit Model"],"prefix":"10.1016","volume":"139","author":[{"given":"Eric G.","family":"Romanowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regis P.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Jerold","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2005.01.021_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(02)00369-9","article-title":"Fluoroquinolone resistance among gram-positive cocci","volume":"2","author":"Hooper","year":"2002","journal-title":"Lancet Inf Dis"},{"key":"10.1016\/j.ajo.2005.01.021_bib2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","article-title":"Emerging fluoroquinolone resistance in bacterial keratitis","volume":"106","author":"Goldstein","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.021_bib3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0161-6420(01)00724-2","article-title":"An in vitro resistance study of levofloxacin, ciprofloxacin and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"108","author":"Kowalski","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.021_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9394(03)00905-X","article-title":"Shifting trends in in vitroantibiotic susceptibilities for common ocular isolates during a period of 15 years","volume":"137","author":"Chalita","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.01.021_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajo.2003.10.026","article-title":"Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis","volume":"137","author":"Marangon","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.01.021_bib6","series-title":"Ophthalmology clinics of North America, cornea and external disease","first-page":"1","article-title":"Infectious disease","author":"Kowalski","year":"2003"},{"key":"10.1016\/j.ajo.2005.01.021_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"4th Generation fluoroquinolones","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.01.021_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.01.021_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00003226-199805000-00008","article-title":"Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels","volume":"17","author":"Kowalski","year":"1998","journal-title":"Cornea"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2005.01.021_bib10","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/314061","article-title":"Clinical pharmacology of gatifloxacin, a new fluoroquinolone","volume":"31","author":"Grasela","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2005.01.021_bib11","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:48:57Z","timestamp":1757594937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939405000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0002939405000905"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2005.01.021","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Successful Treatment of Gatifloxacin-resistant Staphylococcus aureus Keratitis With Zymar\u00ae (Gatifloxacin 0.3%) in a NZW Rabbit Model","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2005.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}